 Ryan Sheridan
Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Polymerase II | 9 | 2025 | 324 | 1.530 |
Why?
| | Transcription Termination, Genetic | 4 | 2025 | 19 | 1.090 |
Why?
| | Transcription Elongation, Genetic | 3 | 2018 | 23 | 0.750 |
Why?
| | RNA Cleavage | 1 | 2018 | 10 | 0.600 |
Why?
| | Transcriptional Activation | 1 | 2018 | 378 | 0.510 |
Why?
| | RNA-Binding Proteins | 3 | 2025 | 422 | 0.470 |
Why?
| | Protein Engineering | 1 | 2016 | 97 | 0.460 |
Why?
| | Centrioles | 2 | 2025 | 44 | 0.410 |
Why?
| | Recombinant Fusion Proteins | 1 | 2016 | 666 | 0.400 |
Why?
| | RNA | 2 | 2021 | 921 | 0.400 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1061 | 0.390 |
Why?
| | Protein Phosphatase 1 | 2 | 2025 | 33 | 0.390 |
Why?
| | Transcriptional Elongation Factors | 3 | 2022 | 40 | 0.380 |
Why?
| | Transcription, Genetic | 5 | 2025 | 1457 | 0.370 |
Why?
| | DNA-Binding Proteins | 4 | 2025 | 1501 | 0.350 |
Why?
| | Poly A | 3 | 2022 | 51 | 0.340 |
Why?
| | Lymph Nodes | 3 | 2024 | 487 | 0.340 |
Why?
| | RNA, Messenger | 6 | 2025 | 2834 | 0.320 |
Why?
| | Single-Cell Analysis | 3 | 2021 | 322 | 0.310 |
Why?
| | HEK293 Cells | 6 | 2025 | 729 | 0.300 |
Why?
| | Protein Biosynthesis | 2 | 2025 | 433 | 0.290 |
Why?
| | Exoribonucleases | 2 | 2019 | 49 | 0.270 |
Why?
| | Promoter Regions, Genetic | 2 | 2024 | 1251 | 0.270 |
Why?
| | Chikungunya Fever | 2 | 2024 | 79 | 0.240 |
Why?
| | Thymocytes | 1 | 2025 | 36 | 0.230 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2025 | 72 | 0.230 |
Why?
| | Ubiquitination | 1 | 2024 | 102 | 0.220 |
Why?
| | Phosphorylation | 6 | 2025 | 1760 | 0.210 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2025 | 336 | 0.200 |
Why?
| | Chikungunya virus | 1 | 2024 | 80 | 0.190 |
Why?
| | Nuclear Proteins | 2 | 2025 | 708 | 0.190 |
Why?
| | Giardia lamblia | 1 | 2022 | 23 | 0.180 |
Why?
| | Cation Transport Proteins | 1 | 2022 | 134 | 0.180 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2021 | 48 | 0.180 |
Why?
| | Alphavirus Infections | 1 | 2021 | 44 | 0.180 |
Why?
| | Peptide Elongation Factors | 2 | 2022 | 15 | 0.170 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 452 | 0.170 |
Why?
| | Viremia | 1 | 2021 | 138 | 0.170 |
Why?
| | Kinetics | 3 | 2019 | 1669 | 0.170 |
Why?
| | RNA, Small Cytoplasmic | 1 | 2020 | 7 | 0.170 |
Why?
| | Receptors, Immunologic | 1 | 2021 | 216 | 0.160 |
Why?
| | Airway Remodeling | 1 | 2020 | 64 | 0.160 |
Why?
| | Cilia | 1 | 2021 | 178 | 0.160 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2022 | 242 | 0.150 |
Why?
| | Wnt Proteins | 1 | 2020 | 133 | 0.150 |
Why?
| | Antigens | 1 | 2021 | 357 | 0.150 |
Why?
| | 3' Flanking Region | 1 | 2018 | 7 | 0.150 |
Why?
| | Transcription Initiation, Genetic | 1 | 2018 | 15 | 0.150 |
Why?
| | Neovascularization, Pathologic | 1 | 2020 | 300 | 0.150 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 192 | 0.140 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 227 | 0.140 |
Why?
| | DNA, Fungal | 1 | 2017 | 80 | 0.130 |
Why?
| | Protein Processing, Post-Translational | 1 | 2019 | 465 | 0.130 |
Why?
| | HeLa Cells | 3 | 2025 | 636 | 0.130 |
Why?
| | Mice | 7 | 2025 | 17789 | 0.130 |
Why?
| | RNA, Viral | 2 | 2021 | 655 | 0.130 |
Why?
| | B-Lymphocytes | 1 | 2022 | 849 | 0.130 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2017 | 104 | 0.130 |
Why?
| | Chromatin | 2 | 2017 | 518 | 0.120 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2016 | 23 | 0.120 |
Why?
| | Sulfonamides | 1 | 2020 | 513 | 0.120 |
Why?
| | Dicistroviridae | 1 | 2015 | 5 | 0.120 |
Why?
| | Internal Ribosome Entry Sites | 1 | 2015 | 4 | 0.120 |
Why?
| | Autoimmunity | 1 | 2022 | 908 | 0.120 |
Why?
| | RNA Precursors | 1 | 2016 | 154 | 0.110 |
Why?
| | Software | 1 | 2020 | 663 | 0.110 |
Why?
| | Animals | 9 | 2025 | 36935 | 0.110 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2020 | 800 | 0.110 |
Why?
| | CRISPR-Cas Systems | 1 | 2016 | 124 | 0.110 |
Why?
| | RNA Splicing | 1 | 2016 | 269 | 0.110 |
Why?
| | Ribosomes | 1 | 2015 | 186 | 0.110 |
Why?
| | Cell Differentiation | 1 | 2022 | 1993 | 0.110 |
Why?
| | Alternative Splicing | 1 | 2016 | 229 | 0.110 |
Why?
| | Autoantibodies | 1 | 2022 | 1498 | 0.110 |
Why?
| | Escherichia coli Proteins | 1 | 2016 | 200 | 0.110 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 927 | 0.110 |
Why?
| | Branchio-Oto-Renal Syndrome | 1 | 2013 | 6 | 0.100 |
Why?
| | Centrosome | 2 | 2025 | 71 | 0.100 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2017 | 405 | 0.100 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2020 | 631 | 0.100 |
Why?
| | Transcription Factor AP-2 | 1 | 2013 | 82 | 0.100 |
Why?
| | Saccharomyces cerevisiae | 1 | 2017 | 557 | 0.100 |
Why?
| | Mutation | 3 | 2018 | 3956 | 0.100 |
Why?
| | Endothelial Cells | 3 | 2024 | 785 | 0.100 |
Why?
| | Nucleic Acid Conformation | 1 | 2015 | 728 | 0.090 |
Why?
| | Humans | 17 | 2025 | 137597 | 0.090 |
Why?
| | Escherichia coli | 1 | 2016 | 815 | 0.090 |
Why?
| | Gene Expression Regulation | 2 | 2018 | 2607 | 0.090 |
Why?
| | Cell Cycle Proteins | 2 | 2025 | 616 | 0.080 |
Why?
| | Cell Line | 3 | 2021 | 2845 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2534 | 0.070 |
Why?
| | Mice, Inbred C57BL | 3 | 2025 | 5764 | 0.070 |
Why?
| | Lung | 1 | 2020 | 4060 | 0.070 |
Why?
| | Protein Binding | 2 | 2025 | 2225 | 0.060 |
Why?
| | Mice, Transgenic | 2 | 2021 | 2166 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2022 | 3717 | 0.060 |
Why?
| | V(D)J Recombination | 1 | 2025 | 8 | 0.060 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2024 | 175 | 0.050 |
Why?
| | Zinc Transporter 8 | 1 | 2022 | 87 | 0.050 |
Why?
| | Haploinsufficiency | 1 | 2022 | 56 | 0.050 |
Why?
| | Immunoglobulin Isotypes | 1 | 2022 | 34 | 0.050 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2022 | 38 | 0.050 |
Why?
| | Respiration | 1 | 2022 | 199 | 0.050 |
Why?
| | Mice, SCID | 1 | 2022 | 366 | 0.050 |
Why?
| | Alphavirus | 1 | 2021 | 21 | 0.050 |
Why?
| | Kupffer Cells | 1 | 2021 | 50 | 0.050 |
Why?
| | Polyadenylation | 1 | 2022 | 42 | 0.040 |
Why?
| | Immunization | 1 | 2024 | 411 | 0.040 |
Why?
| | Phosphorothioate Oligonucleotides | 1 | 2021 | 11 | 0.040 |
Why?
| | Caveolae | 1 | 2021 | 18 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2022 | 145 | 0.040 |
Why?
| | RNA Splicing Factors | 1 | 2021 | 53 | 0.040 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 298 | 0.040 |
Why?
| | Ovalbumin | 1 | 2021 | 183 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2022 | 601 | 0.040 |
Why?
| | Cytoskeletal Proteins | 1 | 2021 | 158 | 0.040 |
Why?
| | DNA | 2 | 2021 | 1459 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2021 | 330 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 283 | 0.040 |
Why?
| | Endocytosis | 1 | 2021 | 172 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2021 | 218 | 0.040 |
Why?
| | Protein Transport | 1 | 2021 | 446 | 0.040 |
Why?
| | Vascular System Injuries | 1 | 2020 | 71 | 0.040 |
Why?
| | Microtubules | 1 | 2021 | 279 | 0.040 |
Why?
| | Phenanthrenes | 1 | 2018 | 13 | 0.040 |
Why?
| | Diterpenes | 1 | 2018 | 31 | 0.040 |
Why?
| | Epoxy Compounds | 1 | 2018 | 33 | 0.040 |
Why?
| | Isotonic Solutions | 1 | 2018 | 38 | 0.040 |
Why?
| | HCT116 Cells | 1 | 2018 | 80 | 0.040 |
Why?
| | Saline Solution, Hypertonic | 1 | 2018 | 41 | 0.040 |
Why?
| | Time Factors | 2 | 2021 | 6829 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 362 | 0.040 |
Why?
| | beta Catenin | 1 | 2020 | 253 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2022 | 1143 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2022 | 1193 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2021 | 484 | 0.030 |
Why?
| | Pulmonary Emphysema | 1 | 2020 | 290 | 0.030 |
Why?
| | Peptide Fragments | 1 | 2021 | 706 | 0.030 |
Why?
| | Gene Expression Regulation, Fungal | 1 | 2017 | 72 | 0.030 |
Why?
| | Gene Expression | 1 | 2021 | 1503 | 0.030 |
Why?
| | Binding Sites | 1 | 2019 | 1303 | 0.030 |
Why?
| | Protein Domains | 1 | 2017 | 289 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2022 | 3018 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 971 | 0.030 |
Why?
| | Lymphocytes | 1 | 2015 | 396 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2021 | 4193 | 0.030 |
Why?
| | Macrophages | 1 | 2021 | 1550 | 0.030 |
Why?
| | Genome, Human | 1 | 2015 | 423 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1768 | 0.020 |
Why?
| | Models, Genetic | 1 | 2015 | 600 | 0.020 |
Why?
| | Mutagenesis | 1 | 2013 | 179 | 0.020 |
Why?
| | Eye | 1 | 2013 | 108 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2013 | 341 | 0.020 |
Why?
| | Aged | 2 | 2020 | 23915 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2015 | 1097 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2013 | 660 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 5084 | 0.020 |
Why?
| | Phenotype | 1 | 2013 | 3200 | 0.010 |
Why?
| | Male | 2 | 2022 | 67788 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 13223 | 0.010 |
Why?
| | Female | 2 | 2022 | 73349 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 33450 | 0.010 |
Why?
| | Adult | 1 | 2020 | 37937 | 0.010 |
Why?
|
|
Sheridan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|